Median Technologies SA (EPA:ALMDT)

France flag France · Delayed Price · Currency is EUR
4.980
-0.140 (-2.73%)
Apr 28, 2026, 5:35 PM CET
94.46%
Market Cap 195.29M
Revenue (ttm) 23.38M
Net Income (ttm) -21.99M
Shares Out 38.14M
EPS (ttm) -1.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 242,090
Average Volume 233,160
Open 5.180
Previous Close 5.120
Day's Range 4.920 - 5.180
52-Week Range 1.192 - 7.270
Beta 0.57
RSI 57.04
Earnings Date Apr 23, 2026

About Median Technologies

Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iSee for imaging services in clinical trials; eyonis for non-invasive diagnostic tests based on imaging for the diagnosis and treatment of patients suffering from cancer; and iCRO, a central imaging service and AI-powered Imagin... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2002
Employees 211
Stock Exchange Euronext Paris
Ticker Symbol ALMDT
Full Company Profile

Financial Performance

In 2024, Median Technologies's revenue was 22.96 million, an increase of 0.79% compared to the previous year's 22.78 million. Losses were -25.24 million, 9.83% more than in 2023.

Financial Statements

News

There is no news available yet.